<DOC>
	<DOCNO>NCT00159315</DOCNO>
	<brief_summary>In randomise , cross-over , control study , total 84 subject include : 12 healthy non-smoking volunteer ; 12 current smoker ; 30 patient mild steroid-naïve asthma ; 30 patient mild-moderate COPD . Each subject 1 screening visit ( necessary ) 2 study visit . At visit 2 3 effect adenosine 5 ` -triphosphate ( ATP ) adenosine 5 ` -monophosphate ( AMP ) challenge , give random order , test .</brief_summary>
	<brief_title>ATP/AMP Challenge Healthy Non-smokers , Smokers , Patients With Asthma , Patients With Chronic Obstructive Pulmonary Disease ( COPD )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>1 . Healthy nonsmoker ( n=12 ) Normal spirometry Forced expiratory volume 1 second ( FEV1 ) reversibility &lt; 15 % inhaled beta2agonists* 2 . At risk ( current smoker ) ( n=12 ) * Normal spirometry , chronic symptom ( cough , sputum production ) FEV1 reversibility &lt; 15 % inhaled beta2agonists* ( * = Global Strategy Diagnosis , Management , Prevention COPD ) 3 . Mild steroidnaïve asthma ( n=30 ) FEV1 equal 80 % 4 . Mildmoderate COPD ( n=30 ) FEV1 5080 % 1 . Pregnancy , breastfeeding , plan pregnancy study . 2 . Fertile woman use acceptable contraceptive measure , judge investigator 3 . Upper respiratory infection within last 4 week 4 . Subjects receive research medication within previous one month 5 . Subjects unable give inform consent 6 . Any psychiatric condition render patient unable understand nature , scope , possible consequence study .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>Healthy Volunteers ( smoker )</keyword>
	<keyword>Healthy Volunteers ( Non-smokers )</keyword>
	<keyword>Asthma Patients</keyword>
	<keyword>COPD Patients</keyword>
</DOC>